Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 507-513

  Mroz, R M ^a   Korniluk, M ^a   Stasiak Barmuta, A ^a   Chyczewska, E ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

BALF; IL 12; IL 18; Sarcoidosis; T cell subsets

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 12; INTERLEUKIN 18; OXYGEN;

ADULT; ARTICLE; BODY PLETHYSMOGRAPHY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LUNG LAVAGE; LYMPHOCYTE; MALE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SARCOIDOSIS; SPIROMETRY; BLOOD; CHEMISTRY; ELECTROCARDIOGRAPHY; FLOW CYTOMETRY; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; MALE; MIDDLE AGED; OXYGEN; PEPTIDYL-DIPEPTIDASE A; PLETHYSMOGRAPHY, WHOLE BODY; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; SPIROMETRY;

EID: 64549153588     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hunninghake GW, Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-173.
2. Mitchell DN, Scadding JG, Heard BE, Hinson KF. Sarcoidosis: histopathological definition and clinical diagnosis. J Clin Pathol 1977; 30: 395-408.
3. Mollers M, Aries SP, Dromann D, Mascher B, Braun J, Dalhoff K. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax 2001; 56: 487-193.
4. Shigehara K, Shijubo N, Ohmichi M et al. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000; 162: 1979-1982.
5. Antoniou KM, Tzouvelekis A, Alexandrakis MG et al. Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res 2006; 26: 400-405.
6. Miller MR, Crapo R, Hankinson J et al. ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005; 26: 153-161.
7. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J 1989; 2: 561-585.
8. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of a cellular components and standardization of BAL. Eur Respir J 1999; 14: 245-248.
9. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T- lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429-434.
10. Semenzato G, Chilosi M, Ossi E et al. Bronchoalveolar lavage and lung histology. Comparative analysis of inflammatory and immunocompetent cells in patients with sarcoidosis and hypersensitivity pneumonitis. Am Rev Respir Dis 1985; 132: 400-404.
11. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234.
12. Mroz RM, Chyczewska E, Korniluk M, Stasiak-Barmuta A, Ossolinska M. Comparison of cellular composition of induced sputum, bronchial washings and bronchoalveolar lavage fluid in sarcoidosis, hypersensitivity pneumonitis and COPD. Pneumonol Alergol Pol 2002; 70: 468-477.
13. Mroz RM, Korniluk M, Stasiak-Barmuta A, Chyczewska E. Comparison of induced sputum and bronchoalveolar lavage fluid cell profile during the treatment of pulmonary sarcoidosis. J Physiol Pharmacol 2007; 58 Suppl 5: 445-452.
14. Ward K, O'Connor C, Odlum C, FitzGerald MX. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989; 44: 6-12.
15. Prasse A, Georges CG, Biller H et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000; 122: 241-248.
16. Taha RA, Minshall EM, Olivenstein R et al. Increased Expression of IL-12 Receptor mRNA in Active Pulmonary Tuberculosis and Sarcoidosis. Am J Respir Crit Care Med 160: 1119-1123.
17. Shigehara K, Shijubo N, Ohmichi M et al. IL-12 and IL-18 are increased and stimulate IFN-g production in sarcoid lungs. J Immunol 2001, 166: 642-649.
18. Hata M, Sugisaki K, Miyazaki E, Kumamoto T, Tsuda T. Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers. Intern Med 2007; 46: 1387-1393.
19. Mroz RM, Korniluk M, Stasiak-Barmuta A, Chyczewska E. Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid of patients with hypersensitivity pneumonitis. J Physiol Pharmacol 2008 (in press).